Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,150 | 97 | 99.6% |
| Education | $16.74 | 1 | 0.4% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,810 | 49 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $461.17 | 4 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $336.67 | 8 | $0 (2024) |
| Gilead Sciences, Inc. | $270.18 | 5 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $265.93 | 3 | $0 (2022) |
| Mauna Kea Technologies, Inc. | $265.59 | 8 | $0 (2024) |
| Echosens North America, Inc. | $139.54 | 1 | $0 (2023) |
| Apollo Endosurgery US Inc | $137.21 | 2 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $117.44 | 3 | $0 (2023) |
| Shionogi Inc | $98.54 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $323.52 | 14 | ABBVIE INC. ($174.61) |
| 2023 | $769.24 | 20 | ABBVIE INC. ($413.55) |
| 2022 | $1,088 | 27 | ABBVIE INC. ($561.07) |
| 2021 | $656.74 | 12 | E.R. Squibb & Sons, L.L.C. ($228.09) |
| 2020 | $240.19 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($121.31) |
| 2019 | $373.78 | 8 | Gilead Sciences, Inc. ($114.25) |
| 2018 | $484.58 | 10 | AbbVie, Inc. ($367.90) |
| 2017 | $230.51 | 8 | Gilead Sciences Inc ($138.02) |
All Payment Transactions
102 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $10.57 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/05/2024 | Mauna Kea Technologies, Inc. | — | Food and Beverage | Cash or cash equivalent | $15.39 | General |
| 05/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $124.52 | General |
| Category: IMMUNOLOGY | ||||||
| 05/06/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: IMMUNOLOGY | ||||||
| 04/12/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: Immunology | ||||||
| 03/19/2024 | CONMED Corporation | CONMED BILIARY (Device) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: GENERAL SURGERY | ||||||
| 03/18/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: Immunology | ||||||
| 03/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.89 | General |
| Category: IMMUNOLOGY | ||||||
| 02/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: IMMUNOLOGY | ||||||
| 2024 | GastroGPO, LLC | — | — | — | $0.00 | Ownership |
| 12/20/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: IMMUNOLOGY | ||||||
| 12/01/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.81 | General |
| Category: IMMUNOLOGY | ||||||
| 11/30/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/09/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $119.25 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2023 | Echosens North America, Inc. | FibroScan (Device) | Food and Beverage | Cash or cash equivalent | $139.54 | General |
| Category: Elastography | ||||||
| 08/22/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $4.29 | General |
| Category: IMMUNOLOGY | ||||||
| 07/27/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $121.03 | General |
| 07/12/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Gastroenterology | ||||||
| 06/08/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $101.73 | General |
| Category: IMMUNOLOGY | ||||||
| 05/12/2023 | W. L. Gore & Associates, Inc. | GORE CARDIOFORM Septal Occluder (Device) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Devices | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 915 | 1,015 | $715,484 | $110,977 |
| 2022 | 17 | 997 | 1,136 | $688,277 | $115,289 |
| 2021 | 17 | 1,181 | 1,402 | $841,451 | $152,078 |
| 2020 | 15 | 1,001 | 1,180 | $621,076 | $118,005 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 210 | 213 | $265,149 | $27,667 | 10.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 77 | 79 | $112,575 | $17,406 | 15.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 96 | 103 | $30,900 | $10,804 | 35.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 112 | $23,744 | $10,351 | 43.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 49 | 50 | $69,732 | $9,460 | 13.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 97 | 145 | $29,000 | $9,403 | 32.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 106 | 108 | $99,850 | $8,663 | 8.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 21 | 21 | $28,155 | $3,837 | 13.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $7,544 | $3,031 | 40.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 20 | $8,140 | $2,897 | 35.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 31 | $4,650 | $2,179 | 46.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 37 | 47 | $7,050 | $1,896 | 26.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $14,280 | $1,850 | 13.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $14,400 | $1,388 | 9.6% |
| 82272 | Stool analysis for blood, by peroxidase activity | Office | 2023 | 33 | 35 | $315.00 | $145.25 | 46.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 194 | 194 | $240,366 | $27,292 | 11.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 116 | 160 | $33,920 | $15,832 | 46.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 56 | 56 | $79,800 | $11,961 | 15.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 124 | 199 | $39,800 | $11,736 | 29.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 95 | 97 | $29,100 | $10,888 | 37.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 104 | 105 | $94,500 | $7,704 | 8.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 32 | 32 | $45,888 | $6,405 | 14.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $11,152 | $4,222 | 37.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 20 | 20 | $28,680 | $3,998 | 13.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $6,512 | $2,681 | 41.2% |
About Dr. Samir Patel, MD
Dr. Samir Patel, MD is a Gastroenterology healthcare provider based in Oak Lawn, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982664736.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samir Patel, MD has received a total of $4,166 in payments from pharmaceutical and medical device companies, with $323.52 received in 2024. These payments were reported across 102 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($4,150).
As a Medicare-enrolled provider, Patel has provided services to 4,094 Medicare beneficiaries, totaling 4,733 services with total Medicare billing of $496,350. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Oak Lawn, IL
- Active Since 03/24/2006
- Last Updated 01/15/2009
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1982664736
Products in Payments
- SKYRIZI (Biological) $504.02
- ZEPOSIA (Drug) $358.59
- RINVOQ (Biological) $347.92
- STELARA (Biological) $316.25
- ENTYVIO (Biological) $200.52
- HUMIRA (Biological) $155.68
- FibroScan (Device) $139.54
- Mavyret (Drug) $124.43
- Epclusa (Drug) $121.94
- X-Tack Endoscopic HeliX Tacking System (Device) $121.51
- MOTEGRITY (Drug) $121.31
- VRAYLAR (Drug) $119.24
- XIFAXAN (Drug) $117.44
- Vemlidy (Drug) $108.10
- Mulpleta (Drug) $98.54
- BOTOX (Biological) $30.71
- LINZESS (Drug) $30.42
- VIBERZI (Drug) $27.65
- CONMED BILIARY (Device) $27.27
- OMVOH (Drug) $26.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Oak Lawn
Dr. Rogelio Silva, M.d, M.D
Gastroenterology — Payments: $446,253
Kamran Ayub, Md, MD
Gastroenterology — Payments: $289,123
Thomas Arndt, Md, MD
Gastroenterology — Payments: $15,103
Brian Blumenstein, Md, MD
Gastroenterology — Payments: $6,525
Imad Elkhatib, M.d, M.D
Gastroenterology — Payments: $5,371
Dr. Hareth Raddawi, Md, MD
Gastroenterology — Payments: $3,959